San Donato Hospital
Rheumatology in Italy typically costs from $2,900 to $5,400. Final expenses depend on the specific diagnosis, whether you access the public system as a resident or use private clinics, and the necessity of biologic medications. Patients from the US can often find savings of 40-60% on private rheumatological care and diagnostics.
Typical Rheumatology Costs in Italy
Major medical hubs for rheumatology are located in Milan and Rome, where the highest concentration of specialized clinics exists. While costs are relatively standardized across private facilities, consulting with a specialist can help you get an accurate price quote tailored to your medical history.
| Italien | Türkei | Österreich | |
| Plasmapherese | von $2,200 | von $1,200 | von $2,000 |
| Medikamentöse Therapie bei systemischem Lupus erythematodes | von $2,200 | von $900 | von $2,000 |
| Intravenöse Kurkumin-Therapie | von $450 | von $350 | von $350 |
| Selektive Apherese | von $3,100 | von $1,550 | - |
| Plasmaaustausch | von $2,250 | von $3,900 | - |
Bookimed erhebt keine zusätzlichen Gebühren für Rheumatologie-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards in der Rheumatologie Behandlung einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind nie allein auf Ihrer Rheumatologie Behandlungsreise.
Italian rheumatology centers maintain high quality through mandatory National Institutional Accreditation and voluntary international certifications. Facilities like Humanitas Research Hospital hold Joint Commission International (JCI) accreditation. Regional authorities and the National Agency for Regional Healthcare Services (AGENAS) monitor clinical outcomes and treatment efficacy across the country.
Bookimed Expert Insight: Italian medical excellence often correlates with research volume rather than just private status. San Raffaele and San Donato Hospital each serve 300,000 patients annually. This high volume allows these Milan-based centers to refine protocols for rare immune diseases that smaller clinics rarely encounter.
Patient Consensus: Patients find that specialized care in Italy matches top European standards. Many recommend tracking your own DAS28 scores and bringing translated records, as formal international monitoring systems are not always the primary focus during consultations.
Italy provides comprehensive access to biological (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) for international patients. Available therapies include TNF inhibitors like adalimumab and etanercept. Interleukin blockers such as tocilizumab and JAK inhibitors like baricitinib or tofacitinib are also routinely prescribed. High-tech centers in Milan and Rome manage these treatments.
Bookimed Expert Insight: Milan serves as the primary hub for advanced rheumatology due to high clinical volumes. San Raffaele and San Donato Hospital each treat 300,000 patients annually. This massive scale often ensures more reliable stock of specialized biologics compared to smaller regional clinics. International patients should target these high-volume centers to avoid potential medication shortages.
Patient Consensus: Patients note that while access to these drugs is excellent, the paperwork can be heavy for non-residents. Many suggest bringing a translated prescription and a 3-month supply to bridge any gaps while coordinating care in Italy.
Patients seeking advanced rheumatology therapy in Italy must present a confirmed diagnosis and evidence of high disease activity. Eligibility is strictly regulated by the Italian Medicines Agency (AIFA). Standard requirements include a 6-month history of failed conventional treatments like Methotrexate before escalating to biologic therapy.
Bookimed Expert Insight: Milan centers like San Raffaele handle over 300,000 patients annually and operate as research hospitals. Our data shows that private clinics in major cities often provide faster diagnostic tracks for international visitors. This avoids long public system wait times for mandatory screenings like TB tests.
Patient Consensus: Visitors note that local doctors may require specific Italian tests even if you have results from home. It is important to have all medical records translated into Italian to speed up the approval process.
Biologic therapy monitoring in Italy involves intensive clinical observation during administration and structured long-term safety checks. Medical teams track infusion reactions, hematologic safety, and infection risks. International patients undergo regular blood work and specialist reviews to manage immunomodulatory effects and ensure treatment efficacy.
Bookimed Expert Insight: Italian research hospitals like San Raffaele and San Donato manage 300,000 patients annually. This high volume across 18+ departments allows for rapid cross-specialty consultations. If a biologic affects liver or heart function, patients get immediate access to top-tier hepatologists or cardiologists in the same facility. This integrated approach is a major safety advantage for international patients with complex histories.
Patient Consensus: Patients emphasize the importance of tracking daily symptoms with photo logs for remote doctor reviews. Many recommend requesting an English summary of the monitoring plan and lab results before leaving Italy.
Rheumatology treatment cycles in Italy typically last 3 to 4 weeks for active phases. Patients usually require 6 to 10 return visits within the first 12 months. Maintenance phases for stable conditions often involve follow-up appointments every 8 to 12 weeks.
Bookimed Expert Insight: Italian research hospitals like San Raffaele and Humanitas combine clinical care with intensive research activities. This duality often lead to tighter monitoring schedules for rare immune diseases compared to general practices. Patients in Milan-based facilities benefit from on-site laboratories that streamline required monthly diagnostic tracking.
Patient Consensus: Patients note that laboratory tests and doctor appointments often happen on different days. Many emphasize the need to plan for in-person visits as remote consultations are rare.
Milan and Rome are Italy's primary hubs for English-speaking rheumatology care. Lombardy and Lazio regions host JCI-accredited facilities with dedicated international departments. These centers specialize in complex autoimmune conditions and rare genetic diseases. Milan is preferred for its advanced research infrastructure and high English proficiency.
Bookimed Expert Insight: Data shows a high concentration of specialized care in Milan, where clinics like San Raffaele and San Donato each serve 300,000 patients yearly. This massive volume allows these centers to fund niche units for rare immune diseases that smaller regional hospitals cannot support. Patients seeking English-speaking specialists should focus on Milan’s private IRCCS-accredited facilities for the most reliable communication and advanced technology.
Patient Consensus: Patients note that while public hospitals offer excellent medical expertise, private facilities in Milan are essential for those requiring English-speaking staff. Many suggest coordinating with a home doctor first since rheumatology often requires long-term follow-up care rather than a single visit.